BAUSCH HEALTH COS INC (BHC) Forecast, Price Target & Analyst Ratings

NYSE:BHCCA0717341071

Current stock price

5.01 USD
-0.02 (-0.4%)
At close:
5.0304 USD
+0.02 (+0.41%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for BAUSCH HEALTH COS INC (BHC).

Forecast Snapshot

Consensus Price Target

Price Target
$7.43
+ 48.29% Upside

Next Earnings Forecast

Earnings Estimate
Release Date
Apr 28, 2026
Period
Q1 / 2026
EPS Estimate
$0.75
Revenue Estimate
2.437B

ChartMill Buy Consensus

Rating
48.89%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
$7.43
Upside
+ 48.29%
From current price of $5.01 to mean target of $7.43, Based on 9 analyst forecasts
Low
$7.36
Median
$7.43
High
$7.65

Price Target Revisions

1 Month
-0.23%
3 Months
1.85%

Price Target Summary

9 Wall Street analysts provided a forecast for the next 12 months for BHC. The average price target is 7.43 USD. This implies a price increase of 48.29% is expected in the next year compared to the current price of 5.01.
The average price target has been revised upward by 1.85% in the past 3 months.

Analyst Ratings & History

Current Analyst Ratings

BHC Current Analyst RatingBHC Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4

Analyst Ratings History

BHC Historical Analyst RatingsBHC Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8

Analyst Ratings Consensus

ChartMill Buy Consensus
48.89%
BHC was analyzed by 9 analysts. The buy percentage consensus is at 49. So analysts seem to be rather neutral about BHC.
In the previous month the buy percentage consensus was at a similar level.
BHC was analyzed by 9 analysts. More opinions would make the average more meaningful.

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-02-25BarclaysMaintains Equal-Weight -> Equal-Weight
2026-01-07Truist SecuritiesMaintains Hold -> Hold
2025-12-09BarclaysInitiate Equal-Weight
2025-05-02RBC CapitalMaintains Sector Perform -> Sector Perform
2025-02-06JefferiesDowngrade Buy -> Hold
2025-01-30RBC CapitalMaintains Sector Perform -> Sector Perform
2024-11-01RBC CapitalMaintains Sector Perform -> Sector Perform
2024-08-02RBC CapitalMaintains Sector Perform -> Sector Perform
2024-08-02Piper SandlerDowngrade Neutral -> Underweight
2024-07-25Truist SecuritiesMaintains Hold -> Hold
2024-07-10Raymond JamesInitiate Market Perform
2024-04-23RBC CapitalMaintains Sector Perform -> Sector Perform
2024-04-12RBC CapitalReiterate Sector Perform -> Sector Perform
2024-04-05RBC CapitalMaintains Sector Perform -> Sector Perform
2024-02-23RBC CapitalMaintains Sector Perform -> Sector Perform
2023-09-20JefferiesUpgrade Hold -> Buy
2023-06-16TD CowenDowngrade Outperform -> Market Perform
2023-05-22JefferiesMaintains Buy -> Buy
2023-05-05RBC CapitalMaintains Sector Perform
2022-09-09Piper SandlerMaintains Neutral
2022-09-01RBC CapitalMaintains Sector Perform
2022-08-10BMO CapitalMaintains Market Perform
2022-08-10RBC CapitalMaintains Sector Perform
2022-07-29RBC CapitalDowngrade Outperform -> Sector Perform
2022-07-29Truist SecuritiesDowngrade Buy -> Hold

Next Earnings Forecast Details

Next Earnings Details

Release Date
Apr 28, 2026
Period
Q1 / 2026
EPS Estimate
$0.75
Revenue Estimate
2.437B
Revenue Q2Q
7.88%
EPS Q2Q
25.69%
Number of Analysts
4

Next Earnings Revisions

Revenue (1 Month)
-0.25%
Revenue (3 Months)
-0.25%
EPS (1 Month)
0.22%
EPS (3 Months)
0.22%

Next Earnings Summary

BHC is expected to report earnings on 4/28/2026. The consensus EPS estimate for the next earnings is 0.75 USD and the consensus revenue estimate is 2.44B USD.
The next earnings revenue estimate has been revised downward by 0.25% in the past 3 months.

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
BHC revenue by date.BHC revenue by date.
8.757B
7.79%
9.625B
9.91%
10.266B
6.66%
10.726B
4.48%
10.713B
-0.12%
9.628B
-10.13%
9.685B
0.59%
9.805B
1.24%
10.041B
2.41%
10.471B
4.28%
EBITDA
YoY % growth
BHC ebitda by date.BHC ebitda by date.
2.863B
2.84%
3.121B
9.01%
3.393B
8.72%
3.807B
12.20%
3.654B
-4.02%
2.687B
-26.46%
2.93B
9.04%
3.018B
3.00%
3.109B
3.02%
N/A
EBIT
YoY % growth
BHC ebit by date.BHC ebit by date.
1.599B
15.04%
1.854B
15.95%
2.185B
17.85%
3.519B
61.05%
3.323B
-5.57%
2.815B
-15.29%
2.88B
2.31%
2.929B
1.70%
2.992B
2.15%
3.158B
5.55%
Operating Margin
BHC operating margin by date.BHC operating margin by date.
18.26%19.26%21.28%32.81%31.02%29.24%29.74%29.87%29.80%30.16%
EPS
YoY % growth
BHC eps by date.BHC eps by date.
3.51
13.96%
3.77
7.41%
3.774.36
15.65%
4.07
-6.65%
3.21
-21.21%
3.18
-0.79%
3.52
10.79%
3.80
7.88%
4.19
10.23%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
0.75
25.69%
1.06
16.54%
1.24
7.09%
1.35
23.04%
Revenue
Q2Q % growth
2.437B
7.88%
2.661B
5.18%
2.732B
1.90%
2.82B
0.86%
EBITDA
Q2Q % growth
793.86M
32.97%
912.54M
-14.64%
989.8M
-39.46%
1.022B
-46.96%
EBIT
Q2Q % growth
481.77M
64.99%
648.42M
41.89%
N/AN/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

BHC Yearly Revenue VS EstimatesBHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B 8B 10B
BHC Yearly EPS VS EstimatesBHC Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2 4 6 8 10

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
-5.25%
EPS Next 5 Year
-1.34%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
-2.16%
Revenue Next 5 Year
-0.94%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
-2.01%
EBIT Next 5 Year
1.11%

BAUSCH HEALTH COS INC / BHC Forecast FAQ

What is the average price target for BAUSCH HEALTH COS INC (BHC) stock?

9 analysts have analysed BHC and the average price target is 7.43 USD. This implies a price increase of 48.29% is expected in the next year compared to the current price of 5.01.

Can you provide the upcoming earnings date for BAUSCH HEALTH COS INC?

BAUSCH HEALTH COS INC (BHC) will report earnings on 2026-04-28.

Can you provide the consensus estimates for BAUSCH HEALTH COS INC next earnings?

The consensus EPS estimate for the next earnings of BAUSCH HEALTH COS INC (BHC) is 0.75 USD and the consensus revenue estimate is 2.44B USD.

Can you provide the consensus rating for BAUSCH HEALTH COS INC stock?

The consensus rating for BAUSCH HEALTH COS INC (BHC) is 48.8889 / 100 . This indicates that analysts generally have a neutral outlook on the stock.